Ayurvedic Herbal Therapies: A Review of Treatment and Management of Dementia.
Ayurveda
ashwagandha
brahmi
dementia
shankhapushpi
turmeric
Journal
Current Alzheimer research
ISSN: 1875-5828
Titre abrégé: Curr Alzheimer Res
Pays: United Arab Emirates
ID NLM: 101208441
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
12
2021
revised:
18
04
2022
accepted:
26
04
2022
pubmed:
6
8
2022
medline:
15
12
2022
entrez:
5
8
2022
Statut:
ppublish
Résumé
Dementia has been characterized by atypical neurological syndromes and several cognitive deficits, such as extended memory loss, strange behavior, unusual thinking, impaired judgment, impotence, and difficulty with daily living activities. Dementia is not a disease, but it is caused by several neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Lewy's bodies. Several drugs and remedies are indicated for alleviating unusual cognitive decline, but no effective pharmacological treatment regimens are available without side effects. Herbal drugs or traditional medicines like Ayurveda have been known for facilitating and corroborating the balance between mind, brain, body, and environment. Ayurvedic therapy comprises 600 herbal formulas, 250 single plant remedies, and natural and holistic health-giving treatments that relieve dementia in patients and increase vitality. Ayurvedic Rasayana herbs [rejuvenating elements] strengthen the brain cells, enhance memory, and decrease stress. The current medicine scenario in the treatment of dementia has prompted the shift in exploring the efficacy of ayurvedic medicine, its safety, and its efficiency. This review presents the literature on several herbal treatments for improving dementia symptomatology and patients' quality of life.
Identifiants
pubmed: 35929620
pii: CAR-EPUB-125357
doi: 10.2174/1567205019666220805100008
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
568-584Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Références
Dementia. World Health Organization. Available from: (Accessed on: 17 April, 2018).2017
Qiu C.; Fratiglioni L.; Aging without dementia is achievable: Current evidence from epidemiological research. J Alzheimers Dis 2018,62(3),933-942
doi: 10.3233/JAD-171037
pubmed: 29562544
Winblad B.; Amouyel P.; Andrieu S.; Defeating Alzheimer’s disease and other dementias: A priority for European science and society. Lancet Neurol 2016,15(5),455-532
doi: 10.1016/S1474-4422(16)00062-4
pubmed: 26987701
Braak H.; Thal D.R.; Ghebremedhin E.; Del Tredici K.; Stages of the pathologic process in Alzheimer’s disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011,70(11),960-969
doi: 10.1097/NEN.0b013e318232a379
pubmed: 22002422
Dementia: Number of people affected to triple in next 30 years. World Health Organization Available from: (Accessed on: August 11, 2022).2017
Mendez M.F.; Early-onset Alzheimer’s disease and its variants. Continuum (Minneapolis Minn) 2019,25(1),34-51
doi: 10.1212/CON.0000000000000687
pubmed: 30707186
Prince M.; Bryce R.; Albanese E.; Wimo A.; Ribeiro W.; Ferri C.P.; The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 2013,9(1),63-75.e2
doi: 10.1016/j.jalz.2012.11.007
pubmed: 23305823
Rashrash M.; Schommer J.C.; Brown L.M.; Prevalence and predictors of herbal medicine use among adults in the United States. J Patient Exp 2017,4(3),108-113
doi: 10.1177/2374373517706612
pubmed: 28959715
Ferran J.; Wilson K.; Doran M.; The early-onset dementias: A study of clinical characteristics and service use. Int J Geriatr Psychiatry 1996,11(10),863-869
doi: 10.1002/(SICI)1099-1166(199610)11:10<863::AID-GPS394>3.0.CO;2-7
Vieira R.T.; Caixeta L.; Machado S.; Epidemiology of early-onset dementia: A review of the literature. Clin Pract Epidemiol Ment Health 2013,9(1),88-95
doi: 10.2174/1745017901309010088
pubmed: 23878613
Read S; Wittenberg R; Karagiannidou M; The effect of midlife risk factors on dementia in older age; London: Public Health England Available from: 2017
Sundström A.; Adolfsson A.N.; Nordin M.; Adolfsson R.; Loneliness increases the risk of all cause dementia and Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci 2020,75(5),919-926
doi: 10.1093/geronb/gbz139
pubmed: 31676909
Sofi F.; Valecchi D.; Bacci D.; Physical activity and risk of cognitive decline: A meta-analysis of prospective studies. J Intern Med 2011,269(1),107-117
doi: 10.1111/j.1365-2796.2010.02281.x
pubmed: 20831630
Guure C.B.; Ibrahim N.A.; Adam M.B.; Said S.M.; Impact of physical activity on cognitive decline, dementia and its subtypes: Meta-analysis of prospective study. BioMed Res Int 2017,2017,1-13
doi: 10.1155/2017/9016924
pubmed: 28271072
Prince M.; Guerchet M.; Prina M.; The epidemiology and impact of dementia: Current state and future trends. In: WHO/MSD/MER/153 Available from: [Accessed on: 17 April, 2018].2015
Mental health. World Health Organization Available from: [Accessed on: 17 April, 2018].2018
Saxena S.; Dua T.; Towards a dementia plan: A WHO guide. World Health Organization Available from: (Accessed August 11, 2022).2018
Vestergaard M.; Hamada T.; Morita M.; Takagi M.; Cholesterol, lipids, amyloid Beta, and Alzheimer’s. Curr Alzheimer Res 2010,7(3),262-270
doi: 10.2174/156720510791050821
pubmed: 19715550
Lanoiselée H.M.; Nicolas G.; Wallon D.; APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer’s disease: A genetic screening study of familial and sporadic cases. PLoS Med 2017,14(3),e1002270
doi: 10.1371/journal.pmed.1002270
pubmed: 28350801
Raux G.; Guyant-Maréchal L.; Martin C.; Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: An update. J Med Genet 2005,42(10),793-795
doi: 10.1136/jmg.2005.033456
pubmed: 16033913
Naj A.C.; Jun G.; Beecham G.W.; Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 2011,43(5),436-441
doi: 10.1038/ng.801
pubmed: 21460841
Mullane K.; Williams M.; Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality. Biochem Pharmacol 2018,158,359-375
doi: 10.1016/j.bcp.2018.09.026
pubmed: 30273553
Schneider J.A.; Arvanitakis Z.; Bang W.; Bennett D.A.; Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007,69(24),2197-2204
doi: 10.1212/01.wnl.0000271090.28148.24
pubmed: 17568013
de la Torre J.C.; The vascular hypothesis of Alzheimer’s disease: Bench to bedside and beyond. Neurodegener Dis 2010,7(1-3),116-121
doi: 10.1159/000285520
pubmed: 20173340
Moon J.H.; Lim S.; Han J.W.; Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults. Stroke 2015,46(4),1024-1030
doi: 10.1161/STROKEAHA.114.008170
pubmed: 25737314
Tiwari R.; Tripathi J.; A critical appraisal of dementia with special reference to Smritibuddhihrass. Ayu 2013,34(3),235-242
doi: 10.4103/0974-8520.123102
pubmed: 24501515
Hirono H.; Watanabe K.; Hasegawa K.; Anti-dementia drugs and hepatotoxicity-Report of two cases. Int J Gerontol 2018,12(3),261-263
doi: 10.1016/j.ijge.2018.02.008
Diwan S.; Hougham G.W.; Sachs G.A.; Strain experienced by caregivers of dementia patients receiving palliative care: Findings from the Palliative Excellence in Alzheimer Care Efforts (PEACE) Program. J Palliat Med 2004,7(6),797-807
doi: 10.1089/jpm.2004.7.797
pubmed: 15684847
Quality indicators for dementia. Available from: [Accessed on: 17 April, 2018].
Sharma A.K.; Kumar R.; Mishra A.; Gupta R.; Problems associated with clinical trials of Ayurvedic medicines. Rev Bras Farmacogn 2010,20(2),276-281
doi: 10.1590/S0102-695X2010000200023
Linde K.; Jonas W.B.; Melchart D.; Willich S.; The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001,30(3),526-531
doi: 10.1093/ije/30.3.526
pubmed: 11416076
Schwartz S.; Psychoactive herbs in veterinary behavior medicine 2008
Frawley D.; Ranade S.; Lele A.; Ayurveda and marma therapy: Energy points in yogic healing 2003
Lad V.D.; Bams M.; Anisha Durve M.S.; Marma points of Ayurveda 2008
Choudhary B.; Approach to neurological disorder in Ayurveda. Indian J Med Res Pharm Sci 2015,2(12),2349-5340
Gokhale B.V.; Ayurvedīya Padārthavijñāna The Philosophy of Āyurveda based on the Philosophies of Vaiáeṣika. Nyāya and Sāṃkhya 1953,Vol. 34
Singh R.H.; The basic tenets of Ayurvedic dietetics and nutrition Ayurvedic Science of Food and Nutrition 2014,15-23
doi: 10.1007/978-1-4614-9628-1_2
Jayasundar R.; Ayurveda: A distinctive approach to health and disease. Curr Sci 2010,8(7),908-914
Dimock E.C.; Hinduism Encyclopedia Britannica Available from: (Accessed on: January 26, 2022).
Chaudhuri K.; Chandola H.M.; Ravishankar B.; Samarakoon S.M.S.; Kumar R.; Evaluation of diet and life style in etiopathogenesis of senile dementia: A survey study. Ayu 2011,32(2),171-176
doi: 10.4103/0974-8520.92554
pubmed: 22408297
Govindaraj P.; Nizamuddin S.; Sharath A.; Genome-wide analysis correlates Ayurveda Prakriti. Sci Rep 2015,5(1),15786
doi: 10.1038/srep15786
pubmed: 26511157
Dubey T.; Chinnathambi S.; Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer’s disease. Arch Biochem Biophys 2019,676,108153
doi: 10.1016/j.abb.2019.108153
pubmed: 31622587
Gupta K.; Mamidi P.; Schizophrenia or dementia or mood disorder with psychosis? Int J Yoga-Philos Psychol Parapsychol 2020,8(2),75-86
Camacho M.; Macleod A.D.; Maple-Grødem J.; Early constipation predicts faster dementia onset in Parkinson’s disease. NPJ Parkinsons Dis 2021,7(1),45
doi: 10.1038/s41531-021-00191-w
pubmed: 34039994
Sharma P.V.; Caraka Samhita, Chaukhambha Orientalia 2011,1-4
Murthy K.R.S.; Susruta Samhita; Chaukhambha Orientalia 2010,1
Valiathan M.S.; The legacy of Charaka. In: Orient 2003
Wang J.; Zhang H.; Tang X.; Cholinergic deficiency involved in vascular dementia: Possible mechanism and strategy of treatment. Acta Pharmacol Sin 2009,30(7),879-888
doi: 10.1038/aps.2009.82
pubmed: 19574993
Brahma S.K.; Debnath P.K.; Therapeutic importance of Rasayana drugs with special reference to their multi-dimensional actions. Aryavaidyan 2003,16,160-163
Rege N.N.; Thatte U.M.; Dahanukar S.A.; Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 1999,13(4),275-291
doi: 10.1002/(SICI)1099-1573(199906)13:4<275::AID-PTR510>3.0.CO;2-S
pubmed: 10404532
Schlebusch L.; Bosch B.A.; Polglase G.; Kleinschmidt I.; Pillay B.J.; Cassimjee M.H.; A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. S Afr Med J 2000,90(12),1216-1223
pubmed: 11234653
Murphy B.M.; Frigo L.C.; Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm 1993,28(12),1199-1204, 1240
pubmed: 10130617
Dwevedi C.; Chandrakar K.; Singh V.; Tiwari S.P.; Indian herbal medicines used for treatment of dementia: An overview. Indian J Pharmacol 2014,1(9),553-571
Mercola J.; Ashwagandha: Ancient herb proven to be a potential cure for Alzheimer’s. Available from: (Accessed on: August 11, 2022).2012
Rao R.V.; Descamps O.; John V.; Bredesen D.E.; Ayurvedic medicinal plants for Alzheimer’s disease: A review. Alzheimers Res Ther 2012,4(3),22
doi: 10.1186/alzrt125
pubmed: 22747839
Russo A.; Izzo A.A.; Cardile V.; Borrelli F.; Vanella A.; Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine 2001,8(2),125-132
doi: 10.1078/0944-7113-00021
pubmed: 11315755
Farooqui A.A.; Farooqui T.; Madan A.; Ong J.H.J.; Ong W.Y.; Ayurvedic medicine for the treatment of dementia: Mechanistic aspects. Evid Based Complement Alternat Med 2018,2018,1-11
doi: 10.1155/2018/2481076
pubmed: 29861767
Narayan M.; Seeley K.W.; Jinwal U.K.; Identification and quantitative analysis of cellular proteins affected by treatment with withaferin a using a SILAC-based proteomics approach. J Ethnopharmacol 2015,175,86-92
doi: 10.1016/j.jep.2015.09.024
pubmed: 26392330
Sun G.Y.; Li R.; Cui J.; Withania somnifera and its withanolides attenuate oxidative and inflammatory responses and up-regulate antioxidant responses in BV-2 microglial cells. Neuromolecular Med 2016,18(3),241-252
doi: 10.1007/s12017-016-8411-0
pubmed: 27209361
Patnaik N.; Role of medicinal plants [Brahmi and Ashwagandha] in the treatment of Alzheimer’s disease. Int J Life Sci Scienti Res 2015,2(1),15-17
Choudhary D.; Bhattacharyya S.; Bose S.; Efficacy and safety of Ashwagandha (Withania somneria (L.) Dunal) root extract in improving memory and cognitive functions. J Diet Suppl 2017,14(6),599-612
doi: 10.1080/19390211.2017.1284970
pubmed: 28471731
Tohda C.; Kuboyama T.; Komatsu K.; Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport 2000,11(9),1981-1985
doi: 10.1097/00001756-200006260-00035
pubmed: 10884056
Kuboyama T.; Tohda C.; Komatsu K.; Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 2005,144(7),961-971
doi: 10.1038/sj.bjp.0706122
pubmed: 15711595
Elhadidy M.E.; Sawie H.G.; Meguid N.A.; Protective effect of Ashwagandha against neurotoxicity induced by aluminium chloride in rats. Asian Pac J Trop Biomed 2018,8(1),59-66
doi: 10.4103/2221-1691.221139
Paul S.; Chakraborty S.; Anand U.; Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Biomed Pharmacother 2021,143,112175
doi: 10.1016/j.biopha.2021.112175
pubmed: 34649336
Singh N.; Bhalla M.; De Jager P.; Gilca M.; An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 2011,8(5S)(Suppl.),208-213
doi: 10.4314/ajtcam.v8i5S.9
pubmed: 22754076
Sharifi-Rad J.; Quispe C.; Ayatollahi S.A.; Chemical composition, biological activity and health-promoting effects of Withania somnifera for pharma-food industry applications. J Food Qual 2021,2021,1-14
doi: 10.1155/2021/8985179
Toden S.; Theiss A.L.; Wang X.; Goel A.; Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis. Sci Rep 2017,7(1),814
doi: 10.1038/s41598-017-00812-6
pubmed: 28400554
Yang F.; Lim G.P.; Begum A.N.; Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005,280(7),5892-5901
doi: 10.1074/jbc.M404751200
pubmed: 15590663
Bryan H.K.; Olayanju A.; Goldring C.E.; Park B.K.; The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 2013,85(6),705-717
doi: 10.1016/j.bcp.2012.11.016
pubmed: 23219527
Gupta S.C.; Prasad S.; Kim J.H.; Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 2011,28(12),1937-1955
doi: 10.1039/c1np00051a
pubmed: 21979811
Wang Y.; Yin H.; Wang L.; Curcumin as a potential treatment for Alzheimer’s disease: A study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med 2013,41(1),59-70
doi: 10.1142/S0192415X13500055
pubmed: 23336507
Begum A.N.; Jones M.R.; Lim G.P.; Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther 2008,326(1),196-208
doi: 10.1124/jpet.108.137455
pubmed: 18417733
Cole G.M.; Lim G.P.; Yang F.; Prevention of Alzheimer’s disease: Omega-3 fatty acid and phenolic antioxidant interventions. Neurobiol Aging 2005,26(Suppl. 1),133-136
doi: 10.1016/j.neurobiolaging.2005.09.005
Brondino N.; Re S.; Boldrini A.; Curcumin as a therapeutic agent in dementia: A mini systematic review of human studies. Sci World J 2014,2014,1-6
doi: 10.1155/2014/174282
pubmed: 24578620
Park S.Y.; Kim H.S.; Cho E.K.; Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol 2008,46(8),2881-2887
doi: 10.1016/j.fct.2008.05.030
pubmed: 18573304
Zhang L.; Fiala M.; Cashman J.; Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer’s disease patients. J Alzheimers Dis 2006,10(1),1-7
doi: 10.3233/JAD-2006-10101
pubmed: 16988474
Kim H.; Park B.S.; Lee K.G.; Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid. J Agric Food Chem 2005,53(22),8537-8541
doi: 10.1021/jf051985c
pubmed: 16248550
Chainani-Wu N.; Safety and anti-inflammatory activity of Curcumin: A component of tumeric. [Curcuma longa]. J Altern Complement Med 2003,9(1),161-168
Voulgaropoulou S.D.; van Amelsvoort T.A.M.J.; Prickaerts J.; Vingerhoets C.; The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain Res 2019,1725,146476
doi: 10.1016/j.brainres.2019.146476
pubmed: 31560864
Nasri H.; Sahinfard N.; Rafieian M.; Turmeric: A spice with multifunctional medicinal properties. J Herbmed Pharmacol 2014,3(1),5-8
Kumar A; Singh A.; Interaction of turmeric (Curcuma longa (L.) with beneficial microbes: A review. 3 Biotech 2017,7(6),357
Prasad S.; Aggarwal B.B.; Benzie I.F.F.; Wachtel-Galor S.; Turmeric, the golden spice Herbal Medicine: Biomolecular and Clinical Aspects 2011
Chanda S.; Ramachandra T.V.; Phytochemical and pharmacological importance of turmeric [Curcuma longa]: A review. J Pharmacol 2019,9(1),16-23p
Chaudhari K.S.; Tiwari N.R.; Tiwari R.R.; Sharma R.S.; Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer’s disease. Ann Neurosci 2017,24(2),111-122
doi: 10.1159/000475900
pubmed: 28588366
Jeyasri R.; Muthuramalingam P.; Suba V.; Ramesh M.; Chen J-T.; Bacopa monnieri and their bioactive compounds inferred Multi-target treatment strategy for neurological diseases: A cheminformatics and system pharmacology approach. Biomolecules 2020,10(4),536
doi: 10.3390/biom10040536
Simpson T.; Pase M.; Stough C.; Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain. Evid Based Complement Alternat Med 2015,2015,1-9
doi: 10.1155/2015/615384
pubmed: 26413126
Majumdar S.; Basu A.; Paul P.; Halder M.; Jha S.; Bacosides and neuroprotection 2013,3639-3660
Bhattacharya S.K.; Bhattacharya A.; Kumar A.; Ghosal S.; Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res 2000,14(3),174-179
doi: 10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O
pubmed: 10815010
Dhanasekaran M.; Tharakan B.; Holcomb L.A.; Hitt A.R.; Young K.A.; Manyam B.V.; Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytother Res 2007,21(10),965-969
doi: 10.1002/ptr.2195
pubmed: 17604373
Anand P.; Nair H.B.; Sung B.; Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010,79(3),330-338
doi: 10.1016/j.bcp.2009.09.003
Kamkaew N.; Scholfield C.N.; Ingkaninan K.; Bacopa monnieri and its constituents is hypotensive in anaesthetized rats and vasodilator in various artery types. J Ethnopharmacol 2011,137(1),790-795
Singh H.K.; Srimal R.C.; Srivastava A.K.; Garg N.K.; Dhawan B.N.; Neuro-psychopharmacological effects of bacosides A and B. Proceedings of Fourth Conference on the Neurobiology of Learning and Memory ,pp. 80
Singh H.K.; Dhawan B.N.; Drugs affecting learning and memory. Lectures Neurobiol 1992,1,189-207
Chowdhuri K.D.; Parmar D.; Kakkar P.; Shukla R.; Seth P.K.; Srimal R.C.; Antistress effects of bacosides of Bacopa monnieri: Modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res 2002,16(7),639-645
Debnath T.; Kim D.; Lim B.; Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules 2013,18(6),7253-7270
doi: 10.3390/molecules18067253
pubmed: 23783459
Madhu K.; Prakash T.; Bacoside-A attenuated in vitro activation of primary astrocyte and microglial cultures. European J Pharm Med Res 2018,5(11),337-341
Nemetchek M.D.; Stierle A.A.; Stierle D.B.; Lurie D.I.; The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J Ethnopharmacol 2017,197,92-100
doi: 10.1016/j.jep.2016.07.073
Abdul M.A.S.; Vijayabalan S.; Madhavan P.; Bacopa monneri, a neuroprotective lead in Alzheimer’s disease: A review on its properties, mechanisms of action and preclinical and clinical studies. Drug Target Insights 2019,13,1177392819866412
doi: 10.1177/1177392819866412
pubmed: 31391778
Rajan K.E.; Preethi J.; Singh H.K.; Molecular and functional characterization of Bacopa monniera: A retrospective review. Evid Based Complement Alternat Med 2015,2015,945217
doi: 10.1155/2015/945217
pubmed: 26413131
Konar A.; Gautam A.; Thakur M.K.; Bacopa monniera [CDRI-08] upregulates the expression of neuronal and glial plasticity markers in the brain of scopolamine induced amnesic mice. Evid Based Complement Alternat Med 2015,2015,837012
doi: 10.1155/2015/837012
pubmed: 26413129
Uabundit N.; Wattanathorn J.; Mucimapura S.; Ingkaninan K.; Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model. J Ethnopharmacol 2010,127(1),26-31
doi: 10.1016/j.jep.2009.09.056
pubmed: 19808086
Hota S.K.; Barhwal K.; Baitharu I.; Prasad D.; Singh S.B.; Ilavazhagan G.; Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiol Dis 2009,34(1),23-39
doi: 10.1016/j.nbd.2008.12.006
pubmed: 19154788
Mathur D.; Goyal K.; Koul V.; Anand A.; The molecular links of re-emerging therapy: A review of evidence of Brahmi. Front Pharmacol 2016,7,44
doi: 10.3389/fphar.2016.00044
pubmed: 26973531
Nandy S.; Dey A.; Mukherjeeb A.; Advances in dammarane-type triterpenoid saponins from Bacopa monnieri: Structure, bioactivity, biotechnology and neuroprotection. Stud Nat Prod Chem 2019,63,489-533
doi: 10.1016/B978-0-12-817901-7.00015-0
Choudhary S.; Kumari I.; Thakur S.; Kaurav H.; Chaudhary G.; Brahmi (Bacopa monnieri): A potential ayurvedic cognitive enhancer
doi: 10.47070/ijapr.v9i5.1917
Dey T.; Mishra S.P.; Memory boosters: A review on Indian Ayurvedic herbs. Int J Innov Res Sci Eng Technol 2017,6(11),21180
Amin H.; Sharma R.; Vyas M.; Shankhapusphi [Convolvulus pluricaulis Choisy]: Validation of the therapeutic claims through contemporary studies. Int J Green Pharm 2014,8(4),193-200
doi: 10.1016/j.ijpharm.2014.08.028
Bhowmik D.; Kumar S.; Paswan S.; Srivastava S.; Traditional Indian herbs Convolvulus pluricaulis and its medicinal importance. J Pharmacogn Phytochem 2012,1,2178-4136
Sethiya N.K.; Nahata A.; Mishra S.H.; Dixit V.K.; An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine. J Chin Integr Med 2009,7(11),1001-1022
doi: 10.3736/jcim20091101
pubmed: 19912732
Chandel U.; Kharoliwal S.; A review on traditional Indian herbs Convolvulus pluricaulis Linn and its medicinal importance. Int J Pure App Biosci 2014,2(6),326-329
Malik J.; Karan M.; Vasisht K.; Nootropic, anxiolytic and CNS-depressant studies on different plant sources of Shankhpushpi. Pharm Biol 2011,49(12),1234-1242
doi: 10.3109/13880209.2011.584539
pubmed: 21846173
Shukla S.P.; Anti-anxiety agents of plant origin. Probe (Memphis) 1981,20,201-208
Dandiya P.C.; The pharmacological basis of herbal drugs acting on CNS. Eastern Pharm 1990,33,39-47
Dubey G.P.; Pathak S.R.; Gupta B.S.; Combined effect of Brahmi (Bacopa monniera) and Shankhpushpi (Convolvulus pluricaulis) on cognitive functions. Pharmacopsychoecol 1994,7,249-251
Manyam B.V.; Dementia in Ayurveda. J Altern Complement Med 1999,5(1),81-88
doi: 10.1089/acm.1999.5.81
pubmed: 10100034
Nahata A.; Patil U.K.; Dixit V.K.; Anxiolytic activity of Evolvulus alsinoides and Convulvulus pluricaulis in rodents. Pharm Biol 2009,47(5),444-451
doi: 10.1080/13880200902822596
Dhingra D.; Valecha R.; Evaluation of the antidepressant like activity of Convolvulus pluricaulis in the mouse forced swim and tail suspension tests. Med Sci Monit 2007,13(7),BR155-BR161
Sharma K.; Bhatnagar M.; Kulkarni S.K.; Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: A comparative evaluation. Indian J Exp Biol 2010,48(5),479-485
pubmed: 20795365
Rai K.; Murthy K.D.; Karanth K.S.; Nalini K.; Rao M.S.; Srinivasan K.K.; Clitoria ternatea root extract enhances acetylcholine content in rat hippocampus. Flioterapia 2002,73(7-8),685-689
doi: 10.1016/S0367-326X(02)00249-6
Pinchas M.; Baranes D.; Dendritic branch intersections are structurally regulated targets for efficient axonal wiring and synaptic clustering. PLoS One 2013,8(12),e82083
doi: 10.1371/journal.pone.0082083
pubmed: 24349189
Sinha S.N.; Dixit V.P.; Madnawat A.V.S.; Sharma O.P.; The possible potentiation of cognitive processing on administration of Convolvulus microphyllus in rats. Indiana Med 1989,1,1-6
Sethiya N.K.; Nahata A.; Singh P.K.; Mishra S.H.; Neuropharmacological evaluation on four traditional herbs used as nervine tonic and commonly available as Shankhpushpi in India. J Ayurveda Integr Med 2019,10(1),25-31
doi: 10.1016/j.jaim.2017.08.012
pubmed: 29530454
Thakur S.; Kaurav H.; Ayurvedic medicinal importance of Sankhapushpi (Convolvulus pluricaulis): Potential cognition boosting herb. Int J Pharm Sci Res Health Care 2021,4
Balkrishna A.; Thakur P.; Varshney A.; Phytochemical profile, pharmacological attributes and medicinal properties of Convolvulus Prostratus-A cognitive enhancer herb for the management of neurodegenerative etiologies. Front Pharmacol 2020,11,171
doi: 10.3389/fphar.2020.00171
pubmed: 32194410
Ganie SH; Ali Z; Das S; Srivastav PS; Sharma MP; Identification of sankhapushpi by morphological, chemical and molecular markers 2015,3(2),1-9
Centella asiatica [asiatic pennywort], Invasive species compendium. CABI Available from: (Accessed August 11, 2022).2017
Inamdar P.K.; Yeole R.D.; Ghogare A.B.; de Souza N.J.; Determination of biologically active constituents in Centella asiatica. J Chromatogr A 1996,742(1-2),127-130
doi: 10.1016/0021-9673(96)00237-3
Xu Y.; Cao Z.; Khan I.; Luo Y.; Gotu Kola (Centella asiatica) extract enhances phosphorylation of cyclic AMP response element binding protein in neuroblastoma cells expressing amyloid beta peptide. J Alzheimers Dis 2008,13(3),341-349
doi: 10.3233/JAD-2008-13311
pubmed: 18431001
Siddiqui B.S.; Aslam H.; Ali S.T.; Khan S.; Begum S.; Chemical constituents of Centella asiatica. J Asian Nat Prod Res 2007,9(4),407-414
doi: 10.1080/10286020600782454
pubmed: 17613628
Ramesh B.N.; Indi S.S.; Rao K.S.J.; Studies to understand the effect of Centella asiatica on Aβ[42] aggregation in vitro. Curr Trends Biotechnol Pharm 2010,4(2),716-724
Lokanathan Y.; Omar N.; Recent updates in neuroprotective and neurogenerative potential of Centella asiatica. Malays J Med Sci 2016,23(1),4-14
Coyle J.; Puttfarcken P.; Glutamate toxicity. Science 1993,262(5134),689-695
doi: 10.1126/science.7901908
pubmed: 7901908
Dhanasekaran M.; Holcomb L.A.; Hitt A.R.; Centella asiatica extract selectively decreases amyloid β levels in hippocampus of Alzheimer’s disease animal model. Phytother Res 2009,23(1),14-19
doi: 10.1002/ptr.2405
pubmed: 19048607
Gray N.; Morré J.; Kelley J.; Centella asiatica protects against the toxic effects of intracellular beta-amyloid accumulation. Planta Med 2013,79(10),1348596
doi: 10.1055/s-0033-1348596
Gray N.E.; Sampath H.; Zweig J.A.; Quinn J.F.; Soumyanath A.; Centella asiatica attenuates amyloid-β-induced oxidative stress and mitochondrial dysfunction. J Alzheimers Dis 2015,45(3),933-946
doi: 10.3233/JAD-142217
pubmed: 25633675
Gray N.E.; Zweig J.A.; Murchison C.; Centella asiatica attenuates Aβ-induced neurodegenerative spine loss and dendritic simplification. Neurosci Lett 2017,646,24-29
doi: 10.1016/j.neulet.2017.02.072
pubmed: 28279707
Ahmad R.M.; Justin T.A.; Manivasagam T.; Nataraj J.; Essa M.M.; Chidambaram S.B.; Asiatic acid nullified aluminium toxicity in in vitro model of Alzheimer’s disease. Front Biosci (Elite Ed) 2018,10(2),287-299
pubmed: 28930619
Sabaragamuwa R.; Perera C.O.; Fedrizzi B.; Centella asiatica (Gotu kola) as a neuroprotectant and its potential role in healthy ageing. Trends Food Sci Technol 2018,79,88-97
doi: 10.1016/j.tifs.2018.07.024
Sun B.; Wu L.; Wu Y.; Therapeutic potential of Centella asiatica and itstriterpenes: A review. Front Pharmacol 2020,11,568032
doi: 10.3389/fphar.2020.568032
pubmed: 33013406
Singh D.C.; Dhyani S.; Kaur G.; A critical review on Guggulu (Commiphora wightii (arn) Bhand.)
Sarup P.; Bala S.; Kamboj S.; Pharmacology and phytochemistry of oleo-gum resin of Commiphora weightii. Scientifca 2015,138039,1-14
Das G.R.; A new hypolipidaemic agent (gugulipid). J Assoc Phys India 1990,38(2),186
pubmed: 2248657
Urizar N.L.; Moore D.D.; GUGULIPID: A natural cholesterol-lowering agent. Annu Rev Nutr 2003,23(1),303-313
doi: 10.1146/annurev.nutr.23.011702.073102
pubmed: 12626688
Perluigi M.; Joshi G.; Sultana R.; In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1–42-induced oxidative stress. J Neurosci Res 2006,84(2),418-426
doi: 10.1002/jnr.20879
pubmed: 16634068
Sultana R.; Ravagna A.; Mohmmad-Abdul H.; Calabrese V.; Butterfield D.A.; Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J Neurochem 2005,92(4),749-758
doi: 10.1111/j.1471-4159.2004.02899.x
pubmed: 15686476
Cui J.; Huang L.; Zhao A.; Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J Biol Chem 2003,278(12),10214-10220
doi: 10.1074/jbc.M209323200
pubmed: 12525500
Szapary P.O.; Wolfe M.L.; Bloedon L.T.; Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial. JAMA 2003,290(6),765-772
doi: 10.1001/jama.290.6.765
pubmed: 12915429
Nohr L.A.; Rasmussen L.B.; Straand J.; Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. Complement Ther Med 2009,17(1),16-22
doi: 10.1016/j.ctim.2008.07.001
pubmed: 19114224
Urizar N.L.; Liverman A.B.; Dodds D.N.T.; A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002,296(5573),1703-1706
doi: 10.1126/science.1072891
pubmed: 11988537
Morley J.E.; Banks W.A.; Lipids and cognition. J Alzheimers Dis 2010,20(3),737-747
doi: 10.3233/JAD-2010-091576
pubmed: 20413879
Eckert G.P.; Kirsch C.; Leutz S.; Wood W.G.; Müller W.E.; Cholesterol modulates amyloid beta-peptide’s membrane interactions. Pharmacopsychiatry 2003,36(Suppl. 2),S136-S143
pubmed: 14574628
Harris J.R.; Milton N.G.N.; Cholesterol in Alzheimer’s disease and other amyloidogenic disorders. Subcell Biochem 2010,51,47-75
doi: 10.1007/978-90-481-8622-8_2
pubmed: 20213540
Saxena G.; Singh S.P.; Pal R.; Singh S.; Pratap R.; Nath C.; Gugulipid, an extract of Commiphora wighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol Biochem Behav 2007,86(4),797-805
doi: 10.1016/j.pbb.2007.03.010
pubmed: 17477963
Shrivastav M.K.; Ahmed I.; Ayurvedic medicinal plant- Guggulu (Commiphora wightii): A birds eye view. Int J Pharm Pharm Sci 2015,2(5),25-29
Sanglongi B.; Rao G.; Baswaraj S.; Pharmaceutical study of Guggulu (Commiphora mukul linn.) W.S.R to its various shodhana properties. Int J Dev Res 2017,7(6),13000-13006
Sanka N.; Santhipriya N.; Nadendla R.R.; An updated review on Anti-Alzheimer’s herbal drugs. J Drug Deliv Ther 2018,8(6),360-372
doi: 10.22270/jddt.v8i6.2049
Joshi H.; Parle M.; Nardostachys jatamansi improves learning and memory in mice. J Med Food 2006,9(1),113-118
doi: 10.1089/jmf.2006.9.113
pubmed: 16579738
Thakur S.; Kaurav H.; Chaudhary G.; Nardostachys jatamansi: Importance of highly significant and endangered plant in Ayurveda. Int J Res Ayurveda Pharm 2021,12(3),124-130
doi: 10.7897/2277-4343.120387
Chandrasekhar K.; Kapoor J.; Anishetty S.; A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 2012,34(3),255-262
doi: 10.4103/0253-7176.106022
pubmed: 23439798
Ng Q.X.; Loke W.; Foo N.X.; A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother Res 2020,34(3),583-590
doi: 10.1002/ptr.6552
pubmed: 31742775
Gupta M.; Kaur G.; Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation. BMC Complement Altern Med 2019,19(1),217
doi: 10.1186/s12906-019-2635-0
pubmed: 31416451
Begum V.H.; Sadique J.; Long term effect of herbal drug Withania somnifera on adjuvant induced arthritis in rats. Indian J Exp Biol 1988,26(11),877-882
pubmed: 3248848
Tohda C.; Komatsu K.; Kuboyama T.; Scientific basis of the anti-dementia drugs of constituents from Ashwagandha. J Trad Med 2005,22(Suppl. 1),176-182
Bhattacharya S.K.; Goel R.K.; Kaur R.; Ghosal S.; Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytother Res 1987,1(1),32-37
doi: 10.1002/ptr.2650010108
Bassani T.B.; Turnes J.M.; Moura E.L.R.; Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer’s type. Behav Brain Res 2017,335,41-54
doi: 10.1016/j.bbr.2017.08.014
pubmed: 28801114
Small G.W.; Siddarth P.; Li Z.; Memory and brain amyloid and tau effects of a bioavailable form of Curcumin in non-demented adults: A double blind placebo-controlled 18-month trial. Am J Geriatr Psychiatry 2018,26(3),266-277
doi: 10.1016/j.jagp.2017.10.010
pubmed: 29246725
Sharman J.; Galeshi R.; Onega L.; Ashby S.; Sharman K.; The efficacy of Curcumin on cognition, depressionand agitation in older adults with Alzheimer’s disease. Open Nutr J 2017,11(1),11-16
doi: 10.2174/1874288201711010011
Mishra M.; Mishra A.K.; Mishra U.; Brahmi (Bacopa monnieri Linn) in the treatment of dementias – a pilot study. Future Healthc J 2019,6(Suppl. 1),69
doi: 10.7861/futurehosp.6-1-s69
pubmed: 31363591
Phakdeekul W.; Kedthongma W.; Effectiveness of Bacopa herb for solving dementia in the elderly. Sys Rev Pharma 2021,12(10),548-553
Sethiya N.K.; Nahata A.; Dixit V.K.; Mishra S.H.; Cognition boosting effect of Canscora decussata (a South Indian Shankhpushpi). Eur J Integr Med 2012,4(1),e113-e121
doi: 10.1016/j.eujim.2011.11.003
Reshma R.G.; Anirudhan R.; Effect of Sankhapushpi [Clitoria ternatea Linn] choorna in the working memory of children. Int J Ayurveda Pharma Res 2019,7(3),42-48
Soumyanath A.; Zhong Y.P.; Henson E.; Centella asiatica extract improves behavioral deficits in a mouse model of Alzheimer’s disease: Investigation of a possible mechanism of action. Int J Alzheimers Dis 2012,2012,1-9
doi: 10.1155/2012/381974
pubmed: 22506133
Wattanathorn J.; Mator L.; Muchimapura S.; Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J Ethnopharmacol 2008,116(2),325-332
doi: 10.1016/j.jep.2007.11.038
pubmed: 18191355
Huang C.; Wang J.; Lu X.; Z-guggulsterone negatively controls microglia-mediated neuroinflammation via blocking IκB-α–NF-κBB signals. Neurosci Lett 2016,619,34-42
doi: 10.1016/j.neulet.2016.02.021
pubmed: 26879835
Raghav S.; Singh H.; Dalal P.K.; Srivastava J.S.; Asthana O.P.; Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Int J Psychiatry 2006,48(4),238-242
pubmed: 20703343
Raina R.S.; Chopra V.S.; Sharma R.; The psychomotor effects of Brahmi and caffeine in healthy male volunteers. J Clin Diagn Res 2009,3,1827-1835
Calabrese C.; Gregory W.L.; Leo M.; Kraemer D.; Bora K.; Oken B.; Effect of standardized Bacopa monniera extract on cognitive function in elderly. A randomized double blind placebo controlled study. J Altern Complement Med 2008,14,707-713
doi: 10.1089/acm.2008.0018
pubmed: 18611150
Carlson J.J.; Farquhar J.W.; DiNucci E.; Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc 2007,107(3),422-432
doi: 10.1016/j.jada.2006.12.011
pubmed: 17324660
Lewis J.E.; Melillo A.B.; Tiozzo E.; A double-blind, randomized clinical trial of dietary supplementation on cognitive and immune functioning in healthy older adults. BMC Complement Altern Med 2014,14(1),43
doi: 10.1186/1472-6882-14-43
pubmed: 24495355
Hashiguchi M.; Ohta Y.; Shimizu M.; Maruyama J.; Mochizuki M.; Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. J Pharm Health Care Sci 2015,1(1),14
doi: 10.1186/s40780-015-0014-7
pubmed: 26819725
Singh M.; Saxena G.; Arya S.; Evaluation of anti-stress effects of Nardostachys jatamansi Dc root extract on clinical patients: A psychological estimation. In: ESSENCE Int J Env Rehab Conser 2017,8(2),54-61
Seddon N.; D’Cunha N.M.; Mellor D.D.; Effects of Curcumin on cognitive function-A systematic review of randomized controlled trials. Explor Res Hypothesis Med 2019,4(1),1-11
doi: 10.14218/ERHM.2018.00024